T-cell therapy

Mahidol University introduces CAR-T cell therapy for B-cell leukaemia in Thailand

Mahidol University has launched Chimeric Antigen Receptor (CAR) modified T-cell therapy for the treatment of B-cell leukaemia, making Thailand the first country in the ASEAN region to adopt this advanced medical technique. Banjong Mahaisawariya, President of Mahidol University, noted that the university’s ability to implement a therapy currently used for certain blood cancers came as a result of a strategic…